Moderators:
Search This Board: 
Created: 01/29/2013 09:14:09 PM - Followers: 81 - Board type: Free - Posts Today: 0

 

ORAGENICS - NYSE Market

https://www.oragenics.com/

""Oragenics is focused on the creation of the TerraCoV2 immunization product candidate to combat the novel coronavirus pandemic and the further development of effective treatments for novel antibiotics against infectious disease. In addition, Oragenics, Inc. has established an exclusive worldwide channel collaboration with Precigen, Inc., a synthetic biology company. The collaborations allow Oragenics access to Precigen's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria.""

https://www.oragenics.com/about

 

Management Team

Alan Joslyn, Ph.D.

President and Chief Executive Officer

Dr. Joslyn was a partner in Lazarus Pharmaceuticals. Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.

Michael Sullivan

Chief Financial Officer

Mr. Sullivan has served as our interim principal executive officer since October 30, 2014 and served as our Chief Financial Officer, Secretary and Treasurer since February 6, 2012. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Group Financial Officer for the Investigative Services and Litigation Consulting Services segment of First Advantage Corporation. Mr. Sullivan is a Florida Certified Public Accountant. He graduated from the Florida State University with a Bachelor of Science in Accounting and a Master of Business Administration.

Dr. Martin Handfield

Senior Vice President of Discovery Research

Dr. Handfield is, the Company’s Senior Vice President of Discovery Research and previously has served as our Director of Research and Development. Prior to joining our Company, Dr. Handfield held a position as Tenured Associate Professor at the Center for Molecular Microbiology and the Department of Oral Biology at the University of Florida College of Dentistry, where he co-invented IVIAT and co-founded ivi Gene Corp. and Epicure Corp. to commercialize this and related technologies. Dr. Handfield holds a B.S. degree in Biochemistry, and a MS degree and PhD in Microbiology and Immunology from the Université Laval College of Medicine in Canada, and did postdoctoral training at the University of Florida.

https://www.oragenics.com/about/management-team


--------------------------------------------------------------------------------------------------------------------------------------------
 
OTC - NEWS
 
http://Oragenics enters into material transfer agreement for COVID-19 vaccine adjuvantSeeking Alpha | 01/07/2021

http://Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine AdjuvantBUSINESS WIRE | 01/07/2021

http://Oragenics, Inc. Announces $6.5 Million Registered Direct OfferingBUSINESS WIRE | 12/24/2020

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OTC - Disclosure's
https://www.otcmarkets.com/stock/OGEN/disclosure

-------------------------------------------------------------------------------------------------------------------------------------------------------------------

Companies News
http://Oragenics working on treatment for oral mucositis with promising AG013 product December 12, 2019

http://Oragenics making 'great progress' enrolling patients in oral mucositis clinical trial October 23, 2019

http://Oragenics, Inc. using Genetically Modified Lactococcus Bacteria found in Yogurt and Milk to create Lantibiotics and Prevent Oral Mucositis May 13, 2019

http://Biotech Outlook 2019: Will the Pressure Continue? December 19, 2018

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Press Releases

Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine

August 20, 2020
 

See this link to read above Press Release or see more - https://www.oragenics.com/news-media/press-releases

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Publications

 
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140
Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of <em>Clostridium difficile</em>-Associated Infection
<i>Chemical Biology & Drug Design</i> Cover Image
Blueprints for the rational design of therapeutic mutacin 1140 variants
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections
Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140
Pharmacokinetic and Pharmacodynamic Evaluation of the Lantibiotic MU1140
Development and validation of a LC–MS quantification method for the lantibiotic MU1140 in rat plasma



 

See this link to read above publications - https://www.oragenics.com/news-media/publications


 

 




 

 

See this link to read above publications - https://www.oragenics.com/news-media/publications?page=2

 

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

Abstracts

Engineering Improved Variants of Mutacin 1140 by Saturation Mutagenesis
Development of OG716, a Novel Lantibiotic Against Clostridium difficile
 

 




 

See this link to read above Abstracts - https://www.oragenics.com/news-media/abstracts

----------------------------------------------------------------------------------------------------------------------------------------------------------
Share Structure
A/S
  

O/S    51,244,130  01/07/2020

Restricted 

Unrestricted 

Held at DTC 

Float 

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#823
Hey whatever it takes to see it rise retired early 05/27/2022 01:06:22 PM
#822
,,,,,,,I’m out THEMASTERS_SON 04/04/2022 02:56:50 PM
#821
3/22 Oragenics Initiates a Pivotal IND-Enabling Toxicology unpathedhaunt 03/22/2022 11:00:14 AM
#820
KABOOM !! ve got movement!! BEIJING BILL 03/03/2022 09:24:32 AM
#819
Looks like word is getting out. :) retired early 02/25/2022 12:20:13 PM
#818
I agree. The buy consensus is at 83%.3 retired early 01/04/2022 02:11:27 PM
#817
HUGE insider buy Nathans123 01/03/2022 08:14:01 PM
#816
OGEN HOD G2G 12/20/2021 11:51:16 AM
#815
lets get this back over $1 shurtha2000 12/20/2021 10:50:52 AM
#814
Oragenics (OGEN) Extends Collaboration with the National Research alisher 12/20/2021 08:46:22 AM
#813
Oragenics Announces Positive COVID-19 Challenge Study Results alisher 12/04/2021 05:48:57 PM
#812
News! Renegade Rich 12/01/2021 11:59:31 AM
#811
ORAGENICS is really on a good way to Mountainman5 09/12/2021 08:27:53 AM
#810
Opps good call. I own both and posted retired early 08/30/2021 10:01:26 AM
#809
How does that help OGEN? oakrock 08/26/2021 01:44:18 AM
#808
Qiagen has received emergency use authorization from the retired early 08/06/2021 01:28:47 PM
#807
OGEN will be a player....opportunity knocks. oakrock 07/28/2021 06:37:21 PM
#806
Been a nice atm. GREGG THE GREEK 07/28/2021 09:16:12 AM
#805
What will happen today? Morning dip into low Lowhndcpr 07/28/2021 09:02:49 AM
#804
Here comes eod volume MADDSTACKER 07/27/2021 02:43:39 PM
#803
$100-$200M from Canadian govt funding ? shurtha2000 07/27/2021 11:07:23 AM
#802
Should thin out soon MADDSTACKER 07/27/2021 10:57:35 AM
#801
EPIC :) retired early 07/27/2021 09:36:20 AM
#800
Could be epic MADDSTACKER 07/27/2021 08:46:59 AM
#799
Big day looming here after OGEN announcement of bigbut 07/27/2021 08:19:57 AM
#798
Nice day here. Need to get back to Lowhndcpr 07/19/2021 04:05:10 PM
#797 O-0 420man 06/07/2021 06:48:12 PM
#796 OGEN cover time :-) dancy 05/18/2021 02:32:53 PM
#795 * * $OGEN Video Chart 04-23-2021 * * ClayTrader 04/23/2021 06:38:01 PM
#794 It's all about the therapeutics, peutics, peutics. :) retired early 04/23/2021 12:14:33 PM
#793 It's time for the CEO to get his trendzone 04/09/2021 01:45:39 PM
#792 Past time.................But I can wait. DMOST 04/09/2021 04:07:38 AM
#791 Time to.move up oxnous 04/08/2021 09:24:03 PM
#790 Sorry, spike.... $$ Golden Cross $$ 04/06/2021 08:53:20 PM
#789 $OGEN Meandering up from the morning low on geocam 03/30/2021 04:40:46 PM
#788 Filled at the gap............ DMOST 03/25/2021 06:17:32 AM
#787 Breaking news OGEN upgraded with a $2.75 PT trendzone 03/24/2021 05:54:04 PM
#786 The gap set around 85 will have to DMOST 03/10/2021 07:15:31 AM
#785 * * $OGEN Video Chart 03-09-2021 * * ClayTrader 03/09/2021 04:57:43 PM
#784 Onward and upward. :) retired early 03/09/2021 01:11:32 PM
#783 Agreed. Bought some today as looks very Condors rugby 03/09/2021 11:37:17 AM
#782 Total corrupt MM manipulation to steal shares before trendzone 03/09/2021 10:49:21 AM
#781 $OGEN is screaming for the top after announcing AlphaStockNews 03/09/2021 08:16:50 AM
#779 Lol That’s What I’m Thinking Has Strong Volume iluvkush 03/09/2021 07:50:37 AM
#778 Nice news and pop this morning. GREGG THE GREEK 03/09/2021 07:43:04 AM
#776 Run? iluvkush 03/09/2021 07:34:10 AM
#775 Are we ready for another run? $$ Golden Cross $$ 03/03/2021 06:41:03 PM
#774 $OGEN The company filed yesterday. Earnings outnabout 03/02/2021 09:07:35 AM
#773 In my opinion BIG NEWS will come soon!!!!!!!!!!!!!!! Mountainman5 03/02/2021 12:58:04 AM
#772 J. B. will move heaven and earth to Mountainman5 03/02/2021 12:57:09 AM
Post Subject